机构:[1]The First Clinical Medical School, Ningxia Medical University, Yinchuan, People’s Republic of China[2]Xuanwu Hospital Capital Medical University, Beijing, People’s Republic of China首都医科大学宣武医院[3]Department of Neurology, Lanzhou University Second Hospital, Lanzhou, People’s Republic of China[4]Guangzhou Women and Children’s Medical Center, Guangzhou, People’s Republic of China[5]Ningxia Medical University, Yinchuan, People’s Republic of China[6]Neuro-Intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of China[7]West China Hospital of Sichuan University, Chengdu, People’s Republic of China四川大学华西医院[8]Department of Neurology, Xijing Hospital, The Air Force Medical University, Xi’an, People’s Republic of China[9]Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, People’s Republic of China[10]Neurology Center, General Hospital of Ningxia Medical University, Yinchuan, People’s Republic of China[11]The Affiliated Hospital of North Sichuan Medical College, Nanchong, People’s Republic of China[12]Meishan People’s Hospital, Meishan, People’s Republic of China[13]Chengdu Seventh People’s Hospital, Chengdu, People’s Republic of China[14]National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of China[15]Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, People’s Republic of China[16]Diagnosis and Treatment Engineering Technology Research Center of Nervous System Diseases of Ningxia, Yinchuan, People’s Republic of China[17]Department of Pediatrics, Yibin Hospital, Children’s Hospital of Chongqing Medical University, Yibin, People’s Republic of China[18]Baoji Central Hospital, Baoji, People’s Republic of China[19]The First People’s Hospital of Tianshui, Tianshui, People’s Republic of China[20]The First Hospital of Lanzhou University, Lanzhou, People’s Republic of China[21]The Affiliated Hospital of Gansu Medical College, Pingliang, People’s Republic of China[22]Gansu Provincial People’s Hospital, Lanzhou, People’s Republic of China[23]The First People’s Hospital of Longnan, Longnan, People’s Republic of China[24]The 940th Hospital of Joint Logistic Support Force of Chinese People’s Liberation Army, Lanzhou, People’s Republic of China[25]Qingyang People’s Hospital, Qingyang, People’s Republic of China[26]The First Affiliated Hospital of Kunming Medical University, Kunming, People’s Republic of China昆明医科大学附属第一医院[27]Emergency Center, General Hospital of Ningxia Medical University, Yinchuan, People’s Republic of China[28]Cerebrospinal Fluid Laboratory, General Hospital of Ningxia Medical University, Yinchuan, People’s Republic of China[29]Department of Infectious Diseases, General Hospital of Ningxia Medical University, Yinchuan, People’s Republic of China[30]General Hospital of Ningxia Medical University, Yinchuan, People’s Republic of China[31]State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, People’s Republic of China[32]NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, Chongqing, People’s Republic of China[33]Department of Neurology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of China重庆医科大学附属第一医院[35]Neurology Center, General Hospital of Ningxia Medical University, Yinchuan, People’s Republic of China
ABSTRACTPreviously, we have reported a cohort of Japanese encephalitis (JE) patients with Guillain-Barré syndrome. However, the evidence linking Japanese encephalitis virus (JEV) infection and peripheral nerve injury (PNI) remains limited, especially the epidemiology, clinical presentation, diagnosis, treatment, and outcome significantly differ from traditional JE. We performed a retrospective and multicenter study of 1626 patients with JE recorded in the surveillance system of the Chinese Center for Disease Control and Prevention, spanning the years 2016 to 2020. Cases were classified into type 1 and type 2 JE based on whether the JE was combined with PNI or not. A comparative analysis was conducted on demographic characteristics, clinical manifestations, imaging findings, electromyography data, laboratory results, and treatment outcomes. Among 1626 laboratory confirmed JE patients, 230 (14%) were type 2 mainly located along the Yellow River in northwest China. In addition to fever, headache, and disturbance of consciousness, type 2 patients experienced acute flaccid paralysis of the limbs, as well as severe respiratory muscle paralysis. These patients presented a greater mean length of stay in hospital (children, 22 years [range, 1-34]; adults, 25 years [range, 0-183]) and intensive care unit (children, 16 years [range, 1-30]; adults, 17 years [range, 0-102]). The mortality rate was higher in type 2 patients (36/230 [16%]) compared to type 1 (67/1396 [5%]). The clinical classification of the diagnosis of JE may play a crucial role in developing a rational treatment strategy, thereby mitigating the severity of the disease and potentially reducing disability and mortality rates among patients.
基金:
Science and Technology Key
Research Program of Ningxia (grant number:
2019BCG01003 and 2023BEG02073) and National Natural
Science Foundation of China (grant number: 81960233
and 82371358).
第一作者机构:[1]The First Clinical Medical School, Ningxia Medical University, Yinchuan, People’s Republic of China
共同第一作者:
通讯作者:
通讯机构:[10]Neurology Center, General Hospital of Ningxia Medical University, Yinchuan, People’s Republic of China[15]Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, People’s Republic of China[16]Diagnosis and Treatment Engineering Technology Research Center of Nervous System Diseases of Ningxia, Yinchuan, People’s Republic of China[32]NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, Chongqing, People’s Republic of China[33]Department of Neurology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of China
推荐引用方式(GB/T 7714):
Guowei Wang,Lianmei Zhong,Manxia Wang,et al.Peripheral nerve injury associated with JEV infection in high endemic regions, 2016-2020: a multicenter retrospective study in China[J].EMERGING MICROBES & INFECTIONS.2024,13(1):2337677.doi:10.1080/22221751.2024.2337677.
APA:
Guowei Wang,Lianmei Zhong,Manxia Wang,Juan Zhou,Shuting Liu...&Zhenhai Wang.(2024).Peripheral nerve injury associated with JEV infection in high endemic regions, 2016-2020: a multicenter retrospective study in China.EMERGING MICROBES & INFECTIONS,13,(1)
MLA:
Guowei Wang,et al."Peripheral nerve injury associated with JEV infection in high endemic regions, 2016-2020: a multicenter retrospective study in China".EMERGING MICROBES & INFECTIONS 13..1(2024):2337677